Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.
- DOI
- 10.1111/hiv.13298
- Published
- 2022-03-21
- Container
- HIV Med
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/hiv.13298,
title = {Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.},
author = {Gedela K and Rajus N and Luis H and Fridayantara WD and Irwanto I and Sukmaningrum E and Wignall FS.},
year = {2022},
journal = {HIV Med},
doi = {10.1111/hiv.13298},
url = {https://doi.org/10.1111/hiv.13298}
}RIS
TY - JOUR TI - Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia. AU - Gedela K AU - Rajus N AU - Luis H AU - Fridayantara WD AU - Irwanto I AU - Sukmaningrum E AU - Wignall FS. PY - 2022 JO - HIV Med DO - 10.1111/hiv.13298 UR - https://doi.org/10.1111/hiv.13298 ER -
APA
K, G., N, R., H, L., WD, F., I, I., E, S., & FS., W. (2022). Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.. HIV Med. https://doi.org/10.1111/hiv.13298
Source records
- europe-pmc · retrieved 2026-09-26T02:07:18.223Z